

Author: Croxford J.L.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.17, Iss.3, 2003-01, pp. : 179-202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


The therapeutic potential of the cannabinoids in neuroprotection
Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. :








The potential of antisense as a CNS therapeutic
By Godfray Jenny Estibeiro Peter
Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. :